Healthcare Services

A key trend shaping the Gestational Diabetes Market involves the Advancements In Diagnostic Solutions For Early Detection Of Health Conditions

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Gestational Diabetes Market Over The 2026–2030 Period?

The gestational diabetes market has experienced robust expansion in recent years. Its size is projected to grow from $9.11 billion in 2025 to $9.93 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.9%. This growth observed historically is attributable to factors such as increasing obesity rates, a rise in pregnancies among older mothers, the implementation of early diabetes screening programs, the expansion of prenatal care services, and greater awareness of pregnancy complications.

The gestational diabetes market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $13.85 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.7%. This projected growth can be attributed to several factors, including the increasing prevalence of gestational diabetes, the widening adoption of digital health monitoring, advancements in prenatal diagnostics, a greater emphasis on preventive maternal care, and supportive healthcare policies. During this period, major trends are expected to involve the rising adoption of blood glucose monitoring, a greater utilization of insulin therapy during pregnancy, an increased focus on lifestyle-based disease management, the expansion of prenatal screening programs, and improved awareness concerning maternal health.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

What Underlying Factors Are Accelerating The Growth Of The Gestational Diabetes Market?

The projected expansion of the gestational diabetes market is anticipated to be fueled by the growing number of obese individuals. Obese individuals are defined as those with a body mass index (BMI) of 30 or above, signifying excessive body fat levels that could lead to considerable health concerns. This demographic is growing as a result of factors such as inactive lifestyles, increased intake of processed, high-calorie foods, genetic factors, and restricted availability of nutritious food and opportunities for physical activity. Addressing gestational diabetes is vital for obese individuals, given their heightened susceptibility to insulin resistance and significant weight gain during gestation, which, if not controlled, can result in adverse outcomes for both the pregnant individual and the infant. As an illustration, data from May 2025 released by the Office for Health Improvement and Disparities, a UK-based government body, showed that approximately 64.5% of adults aged 18 and above in England were classified as overweight or living with obesity between 2023 and 2024, an increase from 64.0% recorded from 2022 to 2023. Consequently, the expanding obese population is a key factor propelling the gestational diabetes market.

How Is The Gestational Diabetes Market Segmented Across Key Categories?

The gestational diabetes market covered in this report is segmented –

1) By Type: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological Treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

How Are Trends Transforming The Gestational Diabetes Market Landscape?

Leading companies in the gestational diabetes market are focused on developing technologically advanced offerings, such as diagnostic kits specifically for gestational diabetes, to provide quick, precise, and convenient early detection methods. A diagnostic kit for gestational diabetes is a medical device utilized to measure blood glucose levels and identify abnormal glucose tolerance in pregnant women, thereby aiding in the early diagnosis and management of the condition. For example, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a diagnostic tool designed to identify gestational diabetes, endometriosis, insulin resistance, and liver disease. This kit accurately measures 2-hydroxybutyrate (2-HB) levels present in venous blood, which is naturally produced by the liver during its standard functions. Elevated 2-HB levels are linked to increased reductive stress, which is associated with various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any existing clinical analyzer and provides results in just 8 minutes, presenting a fast and efficient diagnostic solution.

Who Are The Dominant Players Shaping The Gestational Diabetes Market Landscape?

Major companies operating in the gestational diabetes market are Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, Daiichi Sankyo Company Ltd

Read the full gestational diabetes market report here:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

Which Region Is Projected To Dominate The Gestational Diabetes Market During The Forecast Period?

North America was the largest region in the gestational diabetes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gestational Diabetes Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp

Browse Through More Reports Similar to the Global Gestational Diabetes Market 2026, By The Business Research Company

Tumor Infiltrating Lymphocytes Global Market Report

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Emphysema Global Market Report

https://www.thebusinessresearchcompany.com/report/emphysema-global-market-report

Non Hodgkin Lymphoma Nhl Global Market Report

https://www.thebusinessresearchcompany.com/report/non-hodgkin-lymphoma-nhl-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795